Tajiri Resources Corp. (TSXV: TAJ) ("Tajiri" or the "Company") is pleased to report results of initial trenching from its ...

AMERICA’s BODY corporate looks, as a whole, to be in rude health. One large company after another is presenting record quarterly results. Bosses are raising profit forecasts left and right. Poke and ...

Caris Life Sciences stands out for its broad molecular and AI-driven cancer diagnostics but faces upcoming volatility as the IPO lock-up expires on 15 December 2025. CAI's revenue growth is robust, ...

Understand the fundamentals that drive life. Do basic research that leads to medical breakthroughs and improvements in our world. Study the underlying chemistry of organisms and ecosystems. Help ...

180 Life Sciences Corp (NASDAQ:ATNF) shares are soaring Tuesday after the company provided an update on its Ethereum (CRYPTO: ETH) treasury strategy. What Happened: At the end of July, 180 Life ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the closing of Frazier Life Sciences XII, L.P. (FLS ...

Frazier Life Sciences has gathered an impressive $1.3 billion in capital commitments for its 12th venture fund aimed at private early-stage biotechs. The Palo Alto-based firm said it has now raised ...

With a goal of boosting its life sciences economy into the top three of the global rankings by 2035, the U.K. government is laying out six specific areas of focus to bolster its growth in the industry ...

The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion. Caris Life Sciences, a cancer diagnostics company based in Irving, Texas, uses gene ...

Caris Life Sciences (Nasdaq: CAI), a leading next-generation AI TechBio company and precision medicine pioneer, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, David Dean ...

Irving-based Caris Life Sciences has opened a new $45 million liquid biopsy laboratory in Phoenix. The lab enables the company to further develop and launch its blood-based cancer test called Caris ...

On Wednesday morning, the cancer diagnostics biotech firm Caris Life Sciences rang Nasdaq’s opening bell in New York, marking the company’s awaited initial public offering. Founded in 2008 by David ...